Last reviewed · How we verify

NCT05961020

Effect of Whole-body Vibration on Insulin Resistance in Obese Postmenopausal Women.

Completed NA Last updated 17 May 2024
What this trial tests

NA trial testing Total body vibration in Insulin Resistance in 40 participants. Completed in 8 July 2023.

Timeline
5 November 2022
Primary endpoint
3 January 2023
8 July 2023

Quick facts

Lead sponsorOctober 6 University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment40
Start date5 November 2022
Primary completion3 January 2023
Estimated completion8 July 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

October 6 University

Who can join

Adults 50 to 60, female only, with Insulin Resistance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will be conducted to investigate the Effect of whole-body vibration on insulin resistance in obese postmenopausal women

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Insulin Resistance

Currently open trials in the same condition.

Other October 6 University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05961020.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing